Loading current stock analysis…
Loading current stock analysis…
As of 2026-08-25
On August 18, 2026, Apollo Hospitals launched an initiative called 'Always Open. Always Here.' to provide healthcare services every day, including Sundays, for patient convenience. This initiative was reported by thehindu.com.
On August 19, 2026, it was reported that promoter K Vishweshwar Reddy revoked a pledge on 115,000 equity shares. On August 17, 2026, the same promoter pledged 81,000 equity shares. These transactions were reported to the exchange on August 20, 2026, and August 18, 2026, respectively.
For the quarter ending June 30, 2027 (Q1 FY2026-27), Apollo Hospitals reported Revenue from Operations of ₹7,043.50 crore, an increase from ₹5,842.10 crore in the prior year's quarter (Q1 FY2025-26). Net Profit for the period was ₹610.40 crore, up from ₹441 crore in the same quarter last year. The Net Profit Margin for Q1 FY2026-27 was 8.24%, compared to 7.56% in Q1 FY2025-26. EBITDA for Q1 FY2026-27 was ₹1,140.90 crore, an increase from ₹925.70 crore in Q1 FY2025-26.
As of August 24, 2026, the daily trend is described as a weak downtrend, with the price below the 20-day Simple Moving Average (SMA). However, the weekly trend indicates a moderate uptrend, with the price above the 20-day and 50-day SMAs, and a bullish supertrend signal. Recent daily anomalies include an unusually active upward session on August 14, 2026, and an unusually active downward session on August 12, 2026. A bullish Hammer pattern was detected on the weekly chart ending August 24, 2026.
From March 2019 to March 2024, the shareholding of Domestic Institutional Investors (DIIs) increased from 12.9% to 19.55%, while Foreign Institutional Investors (FIIs) decreased from 44.27% to 45.63%. Promoter shareholding decreased from 34.4% in March 2019 to 29.33% by March 2024.
Showing 3 of 18 candles
Recent drawdown and price variability remain within the producer's contained-risk thresholds.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Trading volume was unusually high, but the closing price did not show a clear directional move.
This indicates increased participation without a clear directional signal.
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | PEAK₹7,043.50 crore | ₹6,605.50 crore | ₹6,477.40 crore | ₹6,303.50 crore | ₹5,842.10 crore |
| Finance Costs | PEAK₹120.40 crore | ₹119.10 crore | ₹112.60 crore | ₹109.60 crore | ₹108.30 crore |
| Other Expenses | PEAK₹1,558.50 crore | ₹1,420.50 crore | ₹1,380.70 crore | ₹1,352.10 crore | ₹1,230 crore |
| Profit Before Tax | PEAK₹785.40 crore | ₹711.40 crore | ₹667.10 crore | ₹668.40 crore | ₹569.10 crore |
| Tax Expense | PEAK₹188.40 crore | ₹170.20 crore | ₹165.70 crore | ₹180.70 crore | ₹141.70 crore |
| Profit Loss For Period | PEAK₹610.40 crore | ₹551.30 crore | ₹516.30 crore | ₹494 crore | ₹441 crore |
Apollo Hospitals Enterprise Limited reported results for the quarter ended June 30, 2026 (Q1 FY2026-27), with revenue reaching ₹7,043.5 crore, crossing the ₹7,000 crore threshold for the first time. Revenue rose 20.6% from the same quarter last year, while profit before tax grew 38.0% to ₹785.4 crore. Both PBT margin and net profit margin expanded, and the quarter continued a pattern of sequential revenue increases.
Revenue from operations reached ₹7,043.5 crore in Q1 FY2026-27, up from ₹5,842.1 crore a year ago. This 20.6% year-on-year growth follows a consistent upward trajectory: each of the previous four quarters has been higher than the one before. Sequentially, revenue grew 6.6% from ₹6,605.5 crore in Q4 FY2025-26, a faster pace than the 2.0% and 2.8% sequential gains in the two preceding quarters.
Profit before tax (PBT) rose 38.0% year-on-year to ₹785.4 crore, and net profit grew 38.4% to ₹610.4 crore. Both growth rates outpaced the 20.6% revenue increase, indicating an improvement in overall profitability.
| Metric | Q1 FY2025-26 | Q1 FY2026-27 | Change |
|---|---|---|---|
| Revenue (₹ Cr) | 5,842.1 | 7,043.5 | +20.6% |
| PBT (₹ Cr) | 569.1 | 785.4 | +38.0% |
| Net Profit (₹ Cr) | 441.0 | 610.4 | +38.4% |
| PBT Margin | 9.74% | 11.15% | +1.41 pp |
| Net Profit Margin | 7.55% | 8.67% | +1.12 pp |
The margin expansion occurred even as one major cost line—other expenses—grew faster than revenue.
Other expenses increased 26.7% year-on-year to ₹1,558.5 crore, outpacing revenue growth by roughly 6 percentage points. Finance costs rose 11.2% to ₹120.4 crore, a slower increase. The effective tax rate declined slightly from 24.9% to 24.0%, adding to net profit growth.
Employee benefit expense was ₹795.8 crore and cost of materials consumed was ₹829 crore.
Segment revenue (which matches consolidated revenue) grew 20.6% year-on-year. Segment profit before tax rose 37.1% to ₹798.8 crore, compared with a 38.0% increase in consolidated PBT. The difference between segment PBT and consolidated PBT was ₹13.4 crore, virtually unchanged from ₹13.6 crore a year ago.
Segment PBT margin improved from 9.97% to 11.34%, a gain of 1.37 percentage points, broadly in line with the consolidated margin improvement.
Paid-up equity share capital remained unchanged at ₹71.9 crore.
Apollo Hospitals reported strong Q1FY27 results with consolidated revenue up 21% YoY to ₹7,043 Cr and EBITDA up 28% YoY to ₹1,092 Cr. Management attributed growth to robust volume increases in high-complexity specialties, strong occupancy (70% vs 65% YoY), and steady international patient demand (26% YoY growth). The company continues to expand capacity with plans to add over 5,800 beds over the next five years, including the recent launch of a 180-bed hospital in Sarjapur and upcoming facilities in Gurugram, Indore, and Ranchi. Apollo HealthCo reported 20% revenue growth, driven by its omni-channel pharmacy network (7,440 stores) and digital platform Apollo 24/7.
Management emphasized a strategic shift towards preventive and patient-centric care, leveraging the integrated healthcare ecosystem to address the rising burden of non-communicable diseases. Key risks include ongoing legal proceedings against a subsidiary regarding land allotment in Karnataka, though an interim stay has been granted, and initial EBITDA losses of ₹38 Cr from new hospitals. Overall, management remains focused on disciplined expansion, prudent capital allocation, and clinical excellence.
Revenue grew 20.6% year-on-year to ₹7,043.5 crore, while profit before tax rose 38.0% to ₹785.4 crore. Net profit margin expanded by 1.12 percentage points to 8.67%. The margin improvement occurred even as other expenses increased 26.7%, outpacing revenue growth. Segment profit before tax grew 37.1%, with segment PBT margin rising 1.37 percentage points, consistent with the consolidated trend.
Exchange disclosures and regulatory announcements for Apollo Hospitals Enterprise.
Apollo Hospitals Enterprise Limited held its 45th Annual General Meeting on August 25, 2026, via video conference. All eight resolutions were passed, including the adoption of financial statements for the year ended March 31, 2026, confirmation of an interim and declaration of a final dividend, re-appointment of directors, and approval to issue non-convertible debentures aggregating up to ₹7,500 million.
MEETING DATE : 25-AUG-2026
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2026. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report together with copy of minutes. |SUBJECT: Shareholders meeting
At Apollo Hospitals Enterprise Limited's Annual General Meeting held on August 25, 2026, shareholders approved eight resolutions with a total vote participation of 86.12% to 86.19%. Key outcomes included the adoption of audited financial statements for FY 2026 (99.9999% in favor), approval of interim and final dividends (99.9676% in favor), and re-appointments of directors Sangita Reddy (96.7154% in favor) and Prathap C Reddy as Executive Chairman (96.9759% in favor). Additionally, the meeting authorized a private placement of non-convertible debentures up to ₹7,500 million (98.8725% in favor) and ratified the remuneration of the Cost Auditor (99.9999% in favor).
On August 19, 2026, promoter K Vishweshwar Reddy revoked a pledge of 115,000 equity shares in Apollo Hospitals Enterprise Limited, valued at INR 1,006,300,000. His post-transaction holding remained unchanged at 1,577,350 shares, representing 0.011% of the company's equity. The company was informed of this pledge release on August 20, 2026.
On August 17, 2026, K Vishweswar Reddy, a promoter of Apollo Hospitals Enterprise Limited, pledged 81,000 equity shares valued at INR 714,900,000. The pledge creation left the total number of securities held by Mr. Reddy unchanged at 1,577,350 shares, representing 0.011% of shareholding. The company received intimation regarding this transaction on August 18, 2026.
Apollo Hospitals Enterprise Limited disclosed the transcript of its presentation on unaudited financial results for the three months ended June 30, 2026, which was delivered on August 13, 2026. The company notified the Bombay Stock Exchange and National Stock Exchange via a filing dated August 19, 2026, pursuant to SEBI Listing Regulations 30 and 46(2). The transcript is accessible via a link on the company's website, with the communication signed by S.M. Krishnan, Senior Vice President – Finance and Company Secretary.
Apollo Hospitals Enterprise Limited disclosed on August 13, 2026, that the audio recording of its analyst call for the financial results for the three months ended June 30, 2026, is available on the company's website.
Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated August 12, 2026, titled "Apollo Hospitals Q1FY27 Results". |SUBJECT: Press Release
Apollo Hospitals Enterprise Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
On August 12, 2026, Apollo Hospitals Enterprise Limited's Board approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as Statutory Auditors for a five-year term commencing after the 46th AGM in 2027, replacing Deloitte Haskins & Sells LLP. The Board also approved unaudited financial results for the three months ended June 30, 2026, reporting consolidated revenue of Rs. 7,043 crore and profit after tax of Rs. 581 crore. Additionally, the Board authorized the transfer of Apollo Healthco Limited's FMCG and wellness distribution undertaking to its wholly-owned subsidiary Apollo Consumer Products Limited on a slump sale basis, subject to shareholder approval, and granted stock options representing 46,798 equity shares under the Apollo ESOP Plan 2024.
Apollo Hospitals Enterprise Limited disclosed its financial results for the quarter ended June 30, 2026, reporting consolidated revenue of INR 70,435 million (up 21% YoY), EBITDA of INR 10,920 million (up 28% YoY), and PAT of INR 5,805 million (up 34% YoY). The company commissioned five new hospitals in the last two quarters, adding approximately 1,000 census beds, while its Digital Health segment achieved a reduced cash loss of INR 97 million. Additionally, shareholders approved a composite scheme on June 24, 2026, to demerge Apollo HealthCo's digital and pharmacy distribution businesses into a separate entity expected to list in Q4 FY27.
On August 12, 2026, Apollo Hospitals Enterprise Limited's Board approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as Statutory Auditors for a five-year term commencing after the 46th AGM in 2027, replacing Deloitte Haskins & Sells LLP. The Board also approved unaudited financial results for the three months ended June 30, 2026, reporting consolidated revenue of Rs. 7,043 crore and profit after tax of Rs. 581 crore. Additionally, the Board authorized the transfer of Apollo Healthco Limited's FMCG and wellness distribution undertaking to its wholly-owned subsidiary Apollo Consumer Products Limited on a slump sale basis, subject to shareholder approval, and granted stock options representing 46,798 equity shares under the Apollo ESOP Plan 2024.
Apollo Hospitals Enterprise Limited announced its 45th Annual General Meeting (AGM) will be held on August 25, 2026, via video conferencing (VC) and other audio-visual means (OAVM). The company proposed a final dividend of ₹10 per share for the financial year ending March 31, 2026, with a record date of August 14, 2026, for determining eligibility. E-voting will be available from August 22 to August 24, 2026.
Apollo Hospitals Enterprise Limited will hold its 45th Annual General Meeting on August 25, 2026, to adopt financial statements for the year ended March 31, 2026, and declare a final dividend of ₹10 per equity share. The meeting will also address the re-appointment of directors Smt. Sangita Reddy and Dr. Prathap C Reddy, with Dr. Reddy also proposed for re-appointment as Executive Chairman for two years from June 25, 2026. Additionally, the company plans to issue non-convertible debentures up to ₹7,500 million on a private placement basis and ratify the remuneration of its cost auditor, M/s. A.N. Raman & Associates, at ₹1.65 million plus statutory levies for the financial year ending March 31, 2027.
Apollo Hospitals Enterprise Limited will hold its 45th Annual General Meeting on August 25, 2026, to adopt financial statements for FY 2025-2026, confirm an interim dividend of ₹10 per share (₹1,437.85 million total), and declare a final dividend of ₹10 per share (₹1,437.85 million total), resulting in a total FY 2025-2026 dividend of ₹20 per share (₹2,875.70 million total). The meeting will also address the re-appointment of directors Smt. Sangita Reddy and Dr. Prathap C Reddy, and the re-appointment of Dr. Prathap C Reddy as Executive Chairman for two years from June 25, 2026. Additionally, members will vote on re-appointing Smt. Rama Bijapurkar as an Independent Director for a second five-year term starting November 12, 2026, and on the issuance of non-convertible debentures up to ₹7,500 million on a private placement basis. The remuneration for the Cost Auditor, M/s. A.N. Raman & Associates, for FY 2026-2027, amounting to ₹1.65 million plus statutory levies, will also be ratified.
Apollo Hospitals Enterprise Limited will hold its Annual General Meeting on August 25, 2026, at 10:15 AM in Chennai via Video Conference. The agenda includes adopting financial statements for the year ended March 31, 2026, confirming interim dividends and approving final dividends, re-appointing Ms. Sangita Reddy and Dr. Prathap C Reddy to director roles, approving Dr. Prathap C Reddy's re-appointment as Executive Chairman for two years, re-appointing Smt. Rama Bijapurkar as an Independent Director, issuing Non-Convertible Debentures up to Rs. 7,500 million on a private placement basis, and ratifying the remuneration of Rs. 1,650,000 payable to the Cost Auditor, AN Raman & Associates, for the period April 1, 2026, to March 31, 2027.
Apollo Hospitals Enterprise Limited will hold its Annual General Meeting on August 25, 2026, at 10:15 AM in Chennai via Video Conference. The agenda includes adopting financial statements for the year ended March 31, 2026, confirming interim dividends and approving final dividends, re-appointing Ms. Sangita Reddy and Dr. Prathap C Reddy to director roles, approving Dr. Prathap C Reddy's re-appointment as Executive Chairman for two years, re-appointing Smt. Rama Bijapurkar as an Independent Director, issuing Non-Convertible Debentures up to Rs. 7,500 million on a private placement basis, and ratifying the remuneration of Rs. 1,650,000 payable to the Cost Auditor, AN Raman & Associates, for the period April 1, 2026, to March 31, 2027.
Apollo Hospitals Enterprise Limited will hold an earnings conference call on August 13, 2026, at 15:00 IST to discuss the unaudited financial results for the quarter ended June 30, 2026. The virtual group meeting is open to investors, analysts, and the general public. A presentation will be included, and dial-in numbers and a registration link are provided.
Apollo Hospitals Enterprise Limited will hold an investor conference call on August 13, 2026, at 3:00 PM IST to discuss the unaudited financial results for the quarter ended June 30, 2026. The financial results are scheduled to be announced on August 12, 2026. Key management personnel, including the Managing Director and CFOs, will be present on the call.
Apollo Hospitals Enterprise Limited has submitted a confirmation certificate for the period ending June 30, 2026, as required by Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The company confirmed that securities received from Depository Participants for dematerialization during the quarter were processed and listed on the stock exchanges. Security certificates received for dematerialization were mutilated and cancelled, with the depositories' names substituted in the register of members within the stipulated time.
Apollo Hospitals Enterprise Limited has submitted a confirmation certificate for the period ending June 30, 2026, as required by Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The company confirmed that securities received from Depository Participants for dematerialization during the quarter were processed and listed on the stock exchanges. Security certificates received for dematerialization were mutilated and cancelled, with the depositories' names substituted in the register of members within the stipulated time.
On June 24, 2026, Apollo Hospitals Enterprise Limited's equity shareholders, secured creditors, and unsecured creditors passed resolutions with the requisite majority approving a composite scheme of arrangement. This scheme involves the demerger of an undertaking into Apollo Healthco Limited, amalgamation of Keimed Private Limited and Apollo Healthtech Limited into Apollo Healthco Limited, and other related corporate restructuring steps. The voting results and scrutinizer's reports have been submitted and are available on the company's website.
On June 24, 2026, Apollo Hospitals Enterprise Limited's equity shareholders, secured creditors, and unsecured creditors passed resolutions with the requisite majority approving a composite scheme of arrangement. This scheme involves the demerger of an undertaking into Apollo Healthco Limited, amalgamation of Keimed Private Limited and Apollo Healthtech Limited into Apollo Healthco Limited, and other related corporate restructuring steps. The voting results and scrutinizer's reports have been submitted and are available on the company's website.
On June 24, 2026, Apollo Hospitals Enterprise Limited's equity shareholders, secured creditors, and unsecured creditors passed resolutions with the requisite majority approving a composite scheme of arrangement. This scheme involves the demerger of an undertaking into Apollo Healthco Limited, amalgamation of Keimed Private Limited and Apollo Healthtech Limited into Apollo Healthco Limited, and other related corporate restructuring steps. The voting results and scrutinizer's reports have been submitted and are available on the company's website.
Recent market and company developments associated with Apollo Hospitals Enterprise.
Apollo Hospitals launches 'Always Open. Always Here.' initiative, offering healthcare services every day, including Sundays, for patient convenience.
ICICI Securities, Recommendations, Hold, Apollo Hospitals Enterprise
Indian stock indices Sensex and Nifty 50 are set to open lower on August 17 due to weak global signals. The Gift Nifty indicated a subdued start, trading below previous closes. Geopolitical tensions and oil prices remain critical factors affecting market sentiment.
In a recent proposal, a parliamentary committee has recommended that hospital room charges not exceed the rates of three-star hotels. The substantial growth of private healthcare as an industry has attracted considerable private equity investment, resulting in valuation spikes and shifts in ownership among hospital chains. However, this raises important questions about the accessibility of healthcare for the average person.
The Sensex slipped 71 points to 78,009, while the Nifty fell 30 points to 24,366. The Nifty Bank gained 144 points to 57,491, while the Midcap index rose 339 points to 63,782.
Sensex Today | Stock Market Highlights: Indian equity markets ended lower on Friday after failing to hold on to the intraday recovery. The Sensex slipped 71 points to 78,009, while the Nifty declined 30 points to 24,366.
The healthcare sector continues to benefit from favourable demand trends, and the Apollo stock could well remain on investors’ radar if it delivers on expansion plans and growth guidance.
ICICI Prudential Life Insurance Company Ltd saw volume of 50.02 lakh shares by 10:45 IST on BSE, a 92.41 fold spurt over two-week average daily volume of 54127 shares
The promoter entity will receive a fee equivalent to 0.25% of the standalone revenue of all listed and unlisted group companies using the brand, capped at a maximum of ₹225 crore. The fee will be levied from 1 June 2026.
Q1 Results Today, 13th August 2026 Live Updates: Follow Q1FY27 live updates from businessline
Sensex, Nifty, Share Prices Live: Indian equities remained subdued despite stronger Asian markets, with firm crude prices and geopolitical risks keeping investors cautious. Domestic inflation, MSCI’s latest reshuffle and expectations around RBI policy are also likely to influence trading sentiment during Thursday’s session.
Q1 Results LIVE Updates: Tata Motors PV, Page Industries, JSW Cement, Aditya Birla Real Estate, Avanti Feeds, Dreamfolks, Godrej Industries, IGL, Indigo Paints, IPCA Labs, Jubilant Foodworks, LG Electronics India, Max Financial Services, Olectra Industries, VST Tillers, Welspun Living, Solar Industries, are among the companies reporting their first quarter earnings today. Earnings reactions also come from Tata Motors CV, Lenskart, Apollo Hospitals among many other stocks. Watch this space for all the LIVE Q1 result updates.
Comprehensive Section Breakdown for Apollo Hospitals Enterprise
Strategic Vision: Integrated healthcare provider operating hospitals, clinics, and pharmacies.
Category: B2B Services
Owns and operates multi-specialty tertiary and quaternary care hospitals specializing in cardiology, oncology, organ transplants, and orthopedics.
Key Products & Services: Apollo Hospitals
Category: Consumer Tech
Manages the retail pharmacy chain, online pharmacy sales, diagnostics bookings, and teleconsultations through Apollo 24/7.
Key Products & Services: Apollo 24/7 • Apollo Pharmacy
Category: B2B Services
Operates primary care clinics (Apollo Clinic), diagnostic laboratories (Apollo Diagnostics), day-surgery units (Apollo Spectra), and cradle care hospitals.
Key Products & Services: Apollo Health and Lifestyle Limited (AHLL) • Apollo Clinic • Apollo Diagnostics • Apollo Spectra
Core Thesis: An omnichannel healthcare model linking physical clinical assets, wholesale pharmaceutical supply chains, and digital patient services.
• Omnichannel Healthcare (Apollo 24/7): The digital platform integrates teleconsultations, laboratory bookings, and prescription delivery, connecting customer data to EHR systems. • Keimed Supply Chain Integration: Keimed acts as the central procurement partner, managing logistics and supplying stock to Apollo's retail pharmacies, hospital dispensaries, and digital hubs. • Clinical Referral Funnel (AHLL): AHLL centers serve as low-cost patient entry points, referring patients requiring advanced care to Apollo's primary multi-specialty hospitals. • Digital Inventory Integration: Centralized ERP systems coordinate drug inventory across physical stores and online distribution centers for efficient last-mile delivery.
• Integrated network of physical and digital healthcare services.
• Wholesale pharmaceutical procurement and distribution capabilities.
• Referral network from primary care to tertiary hospitals.